<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85097821155</prism:url><dc:identifier>SCOPUS_ID:85097821155</dc:identifier><eid>2-s2.0-85097821155</eid><prism:doi>10.3390/biomedicines8120603</prism:doi><article-number>603</article-number><dc:title>The specificity of downstream signaling for a1 and a2ar does not depend on the c-terminus, despite the importance of this domain in downstream signaling strength</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><citedby-count>0</citedby-count><prism:publicationName>Biomedicines</prism:publicationName><dc:publisher>MDPI AG</dc:publisher><source-id>21100840442</source-id><prism:issn>22279059</prism:issn><prism:volume>8</prism:volume><prism:issueIdentifier>12</prism:issueIdentifier><prism:startingPage>1</prism:startingPage><prism:endingPage>21</prism:endingPage><prism:pageRange>1-21</prism:pageRange><prism:coverDate>2020-12-01</prism:coverDate><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag><dc:creator><author seq="1" auid="57204284651"><ce:initials>A.R.</ce:initials><ce:indexed-name>Jain A.R.</ce:indexed-name><ce:surname>Jain</ce:surname><ce:given-name>Abhinav R.</ce:given-name><preferred-name><ce:initials>A.R.</ce:initials><ce:indexed-name>Jain A.R.</ce:indexed-name><ce:surname>Jain</ce:surname><ce:given-name>Abhinav R.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57204284651</author-url><affiliation id="60017672" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017672"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>© 2020 by the authors. Licensee MDPI, Basel, Switzerland.</publishercopyright><ce:para>Recent efforts to determine the high-resolution crystal structures for the adenosine receptors (A<inf>1</inf>R and A<inf>2A</inf>R) have utilized modifications to the native receptors in order to facilitate receptor crystallization and structure determination. One common modification is a truncation of the unstructured C-terminus, which has been utilized for all the adenosine receptor crystal structures obtained to date. Ligand binding for this truncated receptor has been shown to be similar to full-length receptor for A<inf>2A</inf>R. However, the C-terminus has been identified as a location for protein-protein interactions that may be critical for the physiological function of these important drug targets. We show that variants with A<inf>2A</inf>R C-terminal truncations lacked cAMP-linked signaling compared to the full-length receptor constructs transfected into mammalian cells (HEK-293). In addition, we show that in a humanized yeast system, the absence of the full-length C-terminus affected downstream signaling using a yeast MAPK response-based fluorescence assay, though full-length receptors showed native-like G-protein coupling. To further study the G protein coupling, we used this humanized yeast platform to explore coupling to human-yeast G-protein chimeras in a cellular context. Although the C-terminus was essential for Gα protein-associated signaling, chimeras of A<inf>1</inf>R with a C-terminus of A<inf>2A</inf>R coupled to the A<inf>1</inf>R-specific Gα (i.e., Gαi1 versus Gαs). This surprising result suggests that the C-terminus is important in the signaling strength, but not specificity, of the Gα protein interaction. This result has further implications in drug discovery, both in enabling the experimental use of chimeras for ligand design, and in the cautious interpretation of structure-based drug design using truncated receptors.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85097821155" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85097821155&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85097821155&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation id="60017672" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017672"><affilname>Tulane University</affilname><affiliation-city>New Orleans</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author seq="1" auid="57204284651"><ce:initials>A.R.</ce:initials><ce:indexed-name>Jain A.R.</ce:indexed-name><ce:surname>Jain</ce:surname><ce:given-name>Abhinav R.</ce:given-name><preferred-name><ce:initials>A.R.</ce:initials><ce:indexed-name>Jain A.R.</ce:indexed-name><ce:surname>Jain</ce:surname><ce:given-name>Abhinav R.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57204284651</author-url><affiliation id="60017672" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017672"/></author><author seq="2" auid="54780231300"><ce:initials>C.</ce:initials><ce:indexed-name>McGraw C.</ce:indexed-name><ce:surname>McGraw</ce:surname><ce:given-name>Claire</ce:given-name><preferred-name><ce:initials>C.</ce:initials><ce:indexed-name>McGraw C.</ce:indexed-name><ce:surname>McGraw</ce:surname><ce:given-name>Claire</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/54780231300</author-url><affiliation id="60017672" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017672"/></author><author seq="3" auid="7403387058"><ce:initials>A.S.</ce:initials><ce:indexed-name>Robinson A.S.</ce:indexed-name><ce:surname>Robinson</ce:surname><ce:given-name>Anne S.</ce:given-name><preferred-name><ce:initials>A.S.</ce:initials><ce:indexed-name>Robinson A.S.</ce:indexed-name><ce:surname>Robinson</ce:surname><ce:given-name>Anne S.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7403387058</author-url><affiliation id="60017672" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017672"/><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></authors></abstracts-retrieval-response>